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Abstract
Background: Small noncoding RNAs (ncRNAs), including short interfering RNAs (siRNAs) and
microRNAs (miRNAs), can silence genes at the transcriptional, post-transcriptional or translational
level [1, 2].
Results: Here, we show that microRNA-10a (miR-10a) targets a homologous DNA region in the
promoter region of the hoxd4 gene and represses its expression at the transcriptional level.
Mutational analysis of the miR-10a sequence revealed that the 3' end of the miRNA sequence is the
most critical element for the silencing effect. MicroRNA-10a-induced transcriptional gene
inhibition requires the presence of Dicer and Argonautes 1 and 3, and it is related to promoter
associated noncoding RNAs. Bisulfite sequencing analysis showed that the reduced hoxd4
expression was accompanied by de novo DNA methylation at the hoxd4 promoter. We further
demonstrated that trimethylation of histone 3 lysine 27 (H3K27me3) is involved in the miR-10a-
induced hoxd4 transcriptional gene silence.
Conclusion: In conclusion, our results demonstrate that miR-10a can regulate human gene
expression in a transcriptional manner, and indicate that endogenous small noncoding RNA-
induced control of transcription may be a potential system for expressional regulation in human
breast cancer cells.
Background
MicroRNAs (miRNAs) are an important small noncoding
family of 19 to 26 nucleotide long endogenous RNAs
that play critical roles in cognate mRNA cleavage and
translational repression [1, 2]. They participate in a
variety of cell physiological functions such as metabo-
lism, differentiation, morphogenesis, development and
apoptosis [3]. Large numbers of miRNA have been
identified in almost all genetically dissected species
including animals, plants, and viruses (miRBase Release
12.0). Experimental evidence implies that miRNAs can
regulate tumor susceptibility genes [4, 5], and expression
profiling assays have uncovered characteristic miRNA
signatures in human tumors [6, 7]. MicroRNA-induced
transcriptional gene silencing through de novo DNA
methylation or chromatin modification has been
demonstrated in yeast and plants[8]. Although it has
been reported that exogenous siRNAs can mediate
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tion in human cells and miRNA could act as a
cis-regulator to modulate gene expression [9-11], tran-
scriptional inhibition directed by endogenous small
noncoding RNAs remains to be reported.
Homeobox genes are a group of evolutionarily con-
served members that regulate animal morphological
diversity at the organismal and evolutionary level [12].
Computational analyses have identified most vertebrate
and invertebrate Hox genes as putative miRNA targets. It
is believed that knowledge about the relationship
between Hox genes and miRNAs is important for the
understanding of the Hox gene regulatory mechanism in
animal development as well as in tumor invasion and
metastasis [13, 14]. The human hsa-miR-10a locus maps
upstream of hoxb4 and the hsa-miR-10b locus is similarly
situated in the promoter region of hoxd4 ( F i g .1 a ) .H s a -
miR-10a and hsa-miR-10b deviate in only one nucleo-
tide located at the center of their sequence, and the miR-
10 family exhibits strong evolutionary conservation
across a number of animal species such as human,
mouse, zebrafish, Drosophila/fly and chicken (Fig. 1b).
The zebrafish miR-10a and miR-10b loci are not always
coordinately expressed with their downstream hox gene
suggesting that they have independent transcriptional
initiation systems [14]. When expressed, the primary
hsa-miR-10b transcript would be equivalent to a
promoter-associated RNA [15] which could be targeted
by miR-10a and thereby mediate induction of transcrip-
tional gene silence of the hoxd4 locus. Here, we show that
an endogenous miRNA transcriptionally modulates
hoxd4 expression in human cancer cells through de novo
DNA methylation.
Results
MicroRNA-10a inhibits hoxd4 gene expression
To explore whether miR-10a can suppress hoxd4 expres-
sion, the expression levels of the hoxd4 and hoxb4 mRNAs
were compared to those of miR-10a and -10b in several
human cell lines including human breast cancer cells
MDA-MB-231 and MCF7, human mammary epithelial
cells (MCF10A), hepatocellular liver carcinoma cells
(HepG2), cervical carcinoma cells (HeLa) and lung
adenocarcinoma cells (A549) (Fig. 1c, d). The hoxd4
e x p r e s s i o ni sh i g hi nM D A - M B - 2 3 1c e l l s ,b u tl o wi n
MCF-7 cells and MCF10A cells (Fig. 1d). This expression
pattern is similar to that of the adjacent miR-10b locus,
and is consistent with the possibility that these two loci
are coordinately regulated (Fig. 1c). The expression of
miR-10a is higher than of miR-10b in MCF7 cells, but
lower than the miR-10b expression in MDA-MB-231
cells (Fig. 1c), and the expression of miR-10a varies
inversely with the expression of hoxd4 in all six cell types.
This negative correlation indicates that miR-10a might
play a role in modulating hoxd4 gene expression in these
cells. The observation that miRNAs 10a and 10b do not
always present similar expression profiles as their
adjacent genes resemble similar findings in zebrafish
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Figure 1
MiR-10a-induced inhibition of hoxd4 gene expression.( a )
Schematic representation of the miR-10a&b loci upstream of the
hoxd4and hoxb4genes.T heinsertsh owsthen cRNAloc i,theBSP
analysedregion,thesiRNAtargetsites,andtheregionsanalysedby
ChIP in the Hoxd4 promotor. (b) MiRNA10 exhibits high
evolutionary conservation in human, mouse, zebrafish, Drosophila
and chicken. (c) Profile of miR-10a/b expression in cancer cells by
realtimePCR(1:MCF7;2:MDA-MB-231;3:MCF10A:4:HepG2;
5: HeLa; 6: A549). (d) Quantitative RT-PCR analysis of hoxd4 and
hoxb4 gene expression in human cancer cell lines (1: MCF7; 2:
MDA-MB-231; 3: MCF10A: 4: HepG2; 5: HeLa; 6: A549). The
expression miR-10a varies inversely with the expression of hoxd4
inallsixcelltypes.(e)QuantitativePCRanalysisofthehoxd4RNA
levelsinMCF7andMDA-MB-231cellstreatedwithantisensemiR-
10a 2'-O-methyl oligos, miR-196a 2'-O-methyl oligos or negative
control oligos (N.C.). (f) RT-PCR analysis of the hoxd4, hoxd3 and
hoxd8mRNAlevelsinMCF7andMDA-MB-231cellstreatedwith
antisense miR-10a 2'-O-methyl oligos or negative control oligos
(N.C.). (g) Protein analysis of Hoxd4 in MDA-MB-231 cells after
transfectionwithantisensemiR-10a2'-O-methyloligos,miR-196a
2'-O-methyl oligos or negative control oligos (N.C.).
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(page number not for citation purposes)[14] and could indicate that under some conditions the
miRNAs may be regulated independently of their
adjacent hox genes (Fig. 1c, d).
To establish that miR-10a inhibits hoxd4 gene expression,
we first performed in vitro loss-of-function analyses by
silencing the miRNA with antisense oligonucleotides and
assessing hoxd4 gene expression. Quantitative PCR
showed that unlike negative control 2'-O-methyl oligos
(N.C.) or anti-miR-196a, the transfection of a modified
2'-O-methyl miR-10a antisense oligonucleotide (anti-
miR-10a) resulted in a 2-fold increase in hoxd4 mRNA
levels MDA-MB-231 cells and a 4-fold increase in hoxd4
mRNA levels in MCF7 cells(Fig. 1e). No change was
observed in the expression levels of the adjacent hoxd3
and hoxd8 loci (Fig. 1f), indicating that the miR-10a-
induced hoxd4 gene suppression did not affect other
regions on the same chromosome. Nor was there any
change in hoxd4 protein expression levels when MDA-
MB-231 cells were transfected with negative control 2'-O-
methyl oligos (N.C.) or anti-miR-196a (Fig. 1g),
suggesting the observed increase in hoxd4 expression is
a specific effect of the endogenous miR-10a.
MicroRNA-10a decreases hoxd4 gene expression
through transcriptional inhibition
To determine whether miR-10a over-expression would
influence the hoxd4 mRNA expression level, 100 nM
miR-10a duplex was transfected into MCF7 and MDA-
MB-231 cells (Fig. 2a). In both cell lines, the result was a
five to eight fold decrease in the hoxd4 mRNA levels 48
hrs after transfection. Western blot analysis of MDA-MB-
231 cells showed that the Hoxd4 protein levels were
consistent with the results obtained with qPCR (Fig. 2b).
It has been reported that miR-10a could target the 3'UTR
sequence of the hoxd10 gene [13], but based on current
algorithms (miRanda) there are no likely miR-10a target
sites in the 3'UTR of the hoxd4 mRNA. We assessed the
levels of miRNA silencing by cloning the 3'UTRs of these
two genes into a luciferase reporter. We found that
transfection of 100 nM miR-10a duplexes into MCF7
cells caused a 50% decrease in luciferase activity in the
reporter containing the hoxd10 3'UTR while no changes
was detected in cells expressing the reporter with the
hoxd4 3'UTR (Fig. 2c). However, upstream of the hoxd4
transcription initiation site there is a site with near
perfect complementarity to the miR-10a sequence. An
intriguing question is therefore whether miR-10a could
regulate hoxd4 gene expression in a transcriptional
manner. To establish that the loss of hoxd4 expression
was due to transcriptional silencing by miR-10a, we
carried out nuclear run-on experiments (Fig. 2d). Hoxd4
transcription was almost abolished in MCF7 nucleii
when treated with miR-10a duplexes, whereas no
changes were observed when MCF7 was transfected
with the siRNA sid4 designed to target the hoxd4 mRNA
for cleavage. When MCF7 cytoplasmic extracts were
treated similarly, both miR-10a and sid4 significantly
reduced hoxd4 mRNA levels, suggesting that the miR-10a
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Figure 2
MiR-10a modulates hoxd4 gene expression.( a )
Quantitative PCR analysis of hoxd4 gene expression in MCF7
and MDA-MB-231 cells treated with miR-10a duplexes or
mock oligos. (b) Protein analysis of Hoxd4 in MDA-MB-231
cells after transfection with miR-10a. When treated with 100
nM miR-10a duplexes, the expression of Hoxd4 protein was
a l m o s ta b o l i s h e dc o m p a r e dt ot r a n s f e c t i o nw i t h5 0n Mm i R -
10a duplexes or control. (c) Effect of transfection of MCF7
cells with miR-10a duplexes on the relative luciferase activity
of luciferase hoxd10 3'UTR and hoxd4 3'UTR reporter
constructs. (d) Nuclear run-on assay of hoxd4 in the
presence or absence of miR-10a and sid4.( e )R T - P C R
analysis of hoxd4 expression in several human cells after
transfection with miR-10a. The expression of hoxd4 mRNA
was reduced after the transfection of miR-10a duplexes in all
six cell types. (f) Schematic representation of the miR-10a-
G5', -M and -G3' mutants. (g) Hoxd4 expression in MCF7
cells transfected with miR-10a and its mutants. The 3'most
portion of miR-10a sequence is most important for miR-10a
induced gene silence of hoxd4.
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(page number not for citation purposes)induced hoxd4 gene downregulation is achieved at the
transcriptional level.
To test whether miR-10a-induced suppression of hoxd4
mRNA is common in other human cell lines, MCF10A,
HepG2, HeLa and A549 were also investigated. All six
cell types showed a similar tendency towards reduced
hoxd4 expression when transfected with 100 nM miR-10a
(Fig. 2e). To determine which part of the miRNA
sequence is most important for the observed effects, we
mutated the miR-10a sequence in either the first (or
5'most) five basepairs (G5'), in the middle five basepairs
(M), or in the last (or 3'most) five basepairs (G3'), and
analyzed the effects of the mutant miR-10a duplexes in
MCF7 cells (Fig. 2f). Transfection with miR-10a-G5' and
miR-10a-M inhibited hoxd4 mRNA expression to the
same extent as did wildtype miR-10a, however, transfec-
tion with miR-10a-G3' produced nearly no inhibition of
the hoxd4 mRNA expression (Fig. 2g). These data indicate
that miR-10a specifically decrease hoxd4 expression
through transcriptional inhibition, and suggest that the
3'most portion of miR-10a is most important for this
activity.
MicroRNA-10a-induced transcriptional inhibition of
hoxd4 is related to promoter-associated ncRNAs
The human miR-10a and miR-10b sequences deviate in
only one nucleotide, and the mature miR-10a could in
principle regulate hoxd4 by targeting the primary miR-
10b transcript. Expression of intergenic ncRNA loci has
been shown to influence the expression of other, nearby
loci in the human genome, and several noncoding RNAs
have been detected upstream of hoxd4 locus [15, 16]. To
assess whether miRNA-induced transcriptional inhibi-
tion of the hoxd4 locus depends on the target site being
located within a promoter-associated transcript [15],
several RNA duplexes complementary to the hoxd4
promotor were designed. The duplexes were designed
to target nc-hoxd4-34, nc-hoxd4-35,o rnc-hoxd4-36 loci
[17] (si-nc34, si-nc35, si-nc36, respectively) or the non-
transcribed sequence spacing these loci (siD1, siD2)
(Fig. 1a). In accordance with the idea that RNA
expression is required for promoter targeting, we found
that two of the siRNAs targeting ncRNA loci (si-nc34 and
si-nc36) in MCF7 cells inhibited hoxd4 expression,
whereas the siRNAs targeting the intervening non-
transcribed sequence siD1 and siD2 had almost no
effect in hoxd4 expression (Fig. 3a). Further analysis of
the effect of the siRNAs showed that both si-nc34 and si-
nc36 clearly reduced the levels of their respective
noncoding transcript targets (Fig. 3b), whereas si-nc35
did not affect the expression level of nc-hoxd4-35,
possibly also explaining the failure of this siRNA to
affect hoxd4 expression. To explore whether the
secondary structure of the promoter-associated RNA
target would influence the observed transcriptional
inhibition, two RNA duplexes was designed to target
the pri-miR-10b transcript either at the stem region
(siP1) or the loop region (siP2; Fig. 3c). The siP1 duplex
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Figure 3
MiR-10a-induced transcriptional inhibition of hoxd4 is
related to promoter-associated ncRNAs.( a )E f f e c t so f
promoter target site on siRNA-induced inhibition of hoxd4
expression in MCF7 cells. Si-nc34 and si-nc36 inhibited hoxd4
mRNA expression in MCF7 cells, whereas siD1 and siD2 had
almost no effect in hoxd4 mRNA expression. (b) RT-PCR
assay of ncRNAs in the hoxd4 promotor region of MCF7 cells
after transfection with si-nc34, si-nc35 and si-nc36. Si-nc35
did not affect the expression level of nc-hoxd4-35.( c )
Schematic representation of the siP1 and siP2 target sites on
hsa-miR-10b. SiP1 and SiP2 were designed to target the stem
and lopp region, respectively, of has-miR-10b precusor. (d)
Hoxd4 expression after transfection of MCF7 cells with siP1
and siP2. SiP2 couldn't affect the hoxd4 mRNA expression.
(e) Expression of hoxd4 and hoxb4 (relative to b-actin)i n
MCF7 and MDA-MB-231 cells after transfection with miR-
10a and miR-10b duplexes. MiR-10a and -10b couldn't target
their own primary transcript to modulate downstream gene
expression. (f) Hoxd4 expression in MCF7 cells after RNAi
against Argonautes and Dicer mRNAs. The results suggested
that Dicer, AGO1 and AGO3 are required for the induction
of transcriptional inhibition by miR-10a duplexes.
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(page number not for citation purposes)decreased the expression of hoxd4 even more strongly
than did the miR-10a duplex, whereas transfection with
the siP2 duplex had no affect on the hoxd4 expression
(Fig. 3d). The data thus suggest that miRNA-induced
transcriptional inhibition is mediated through interfer-
ence with promoter-associated transcripts, and that the
secondary structure of the promoter-associated ncRNAs
can influence the inhibitory effect.
MiR-10a/b do not silence transcription of immediate
downstream genes
If the transcriptional inhibition of hoxd4 expression is
achieved by miR-10a targeting the miR-10b primary
transcript, then the possibility remains that it could also
target its own primary transcript. To assess this possibi-
lity and also whether miR-10b might target the primary
miR-10a transcript and thereby induce transcriptional
inhibition its adjacent hoxb4 locus, the hoxd4 and hoxb4
mRNA levels in MCF7 and MDA-MB-231 cells were
evaluated by quantitative RT-PCR. The results show that
hoxd4 expression was reduced when transfected with the
miR-10a duplexes, and similarly that hoxb4 was down-
regulated after transfection with miR-10b. Neither miR-
10a nor miR-10b reduced the expression of their
respective immediate downstream hox locus, possibly
indicating that none of these miRNAs are able to target
their own primary transcripts (Fig. 3e). MiR-10a/b and
miR-320 are both encoded in the promoter region of
genes, and the observation that miR-320 has as a cis-
regulatory role may be very important in miRNA
research[11]. Although, there are no negative correla-
tions between the expression of the miRNAs and their
respective host genes, and miRNAs target their homo-
logous pre-miRNA sites to modulate gene expression
would be also another interesting research topic in
molecular biology.
Dicer and AGO1/3 proteins are involved in miR-10a
induced transcriptional gene inhibition
Previous studies have shown that siRNAs targeting
selected promoter regions of human genes require the
recruitment of the Argonaute 1 (Ago1) and Argonaute 2
(Ago2) [18, 19]. Also knockdownofDicer relieve the
transcriptional inhibition and attenuate abnormal pro-
moter methylation in human cells [20]. We decided to
test whether transcriptional inhibition induced by
endogenous small noncoding RNAs is Ago-dependent,
a n da l s ow h e t h e rD i c e ri si n v o l v e di nt h i sp r o c e s s .
Specific siRNAs targeting Agos 1–4( s i A g o 1 ,s i A g o 2 ,
siAgo3 and siAgo4) and Dicer (siDicer) were shown to
knock-down the corresponding Argonaute and Dicer
mRNA efficiently [19, 21]. Each of these siRNAs was
transfected into MCF7 cells, either alone or in combina-
tion with the miR-10a duplex. Co-transfected with the
miR-10a duplex, siAgo1 or siDicer almost completely
prevented the reduction in hoxd4 expression induced by
miR-10a (Fig. 3f). SiAgo3 produced a similar, but less
pronounced effect. These data show that AGO1 and
AGO3 are required for the induction of transcriptional
inhibition by endogenous small noncoding RNAs. The
effect of Dicer knockdown further suggests involvement
of this protein in DNA methylation of the hoxd4
promotor.
MicroRNA-10a-induced inhibition of transcription is
associated with DNA methylation of the hoxd4 promotor
Transcriptional silencing is commonly associated with
epigenetic chromatin modifications. To test whether
miR-10a suppresses hoxd4 expression by de novo DNA
methylation, MCF7 and MDA-MB-231 cells were treated
for 5 days with 0.75 μM 5-Aza-2'-deoxycytidine (5-aza-
dC), a DNA methylotransferase (DNMT) inhibitor. In
MCF7 cells, the 5-aza-dC treatment clearly upregulated
the expression of the p15 gene, whose promotor is
normally methylated, but did neither affect the expres-
sion of the unmethylated gapdh gene nor affect the
expression of miR-10a (Fig. 4a). Treatment with 5-aza-
dC increased the hoxd4 mRNA level about 5-fold in
MCF7cells, comparedtoonly2-foldinMDA-MB-231cell
linesfor5days(Fig.4b).ToshowthatmiR-10acansilence
hoxd4 expression by promoter methylation, MCF7 cells
and MDA-MB-231 cells were transfected with either the
miR-10a duplexes or anti-miR-10a, and then treated with
1 μM 5-aza-dC for 48 h. We found that after inhibiton of
the DNA methylotransferase activity, miR-10a could no
longer silence hoxd4 mRNA expression (Fig. 4c).
Targeting promoters with siRNAs have been shown to
relative with the facultative heterochromatin marks
H3K9me2 and H3K27me3 in human cells [9, 18]. To
determine whether miR-10a could induce these repres-
sive histone modifications, we used chromatin immu-
noprecipitation (ChIP) to screen the hoxd4 promoter for
H3K9me2 and H3K27me3 at regions overlapping the
miR-10a target site (Chip Box1: -1081 ~ -972) and the
bisulphite sequencing PCR (BSP) detection site (Chip
Box2: -330 ~ -122). Western blot analysis demonstrated
the presence of H3K9me2 and H3K27me3 in the
promoter region of the hoxd4 g e n e( F i g .4 d ) .A f t e r
transfection with miR-10a, an increase in H3K27me3 in
the two analysed regions (Box1 and Box2) was observed
in both MCF7 cells and MDA-MB-231 cells (Fig. 4e). We
next analysed the DNA methylation status by performing
bisulphite sequencing of the hoxd4 promoter. Aberrant
methylation is often observed in cancer cells. CpG and
CpNpG methylation are both strongly correlated with
gene silencing in plants. CpNpG methylation is rare in
the human genome, and no functional implications for
BMC Molecular Biology 2009, 10:12 http://www.biomedcentral.com/1471-2199/10/12
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(page number not for citation purposes)gene silencing have ever been documented[22]. Consis-
tents with previous studies [22, 23], we found no
CpNpG methylation in the our bisulfite-sequenced
region (BSP Sequencing Region: -330 ~ -122). Cultures
treated with mock duplexes presented CpG methylation
in this region, but consistent with the observation that
the hoxd4 mRNA level is lower in MCF7 than in MDA-
MB-231 cell lines, the hoxd4 promoter region was clearly
more densely methylated in MCF7 cells than in MDA-
MB-231 cells. When the cultures were transfected with
miR-10a duplexes, the extent of methylation increased
compared to cultures treated with control RNA duplexes.
Contrarily, when cells were treated with 2'-O-methyl-
miR-10a (anti-miR-10a), we found that the extent of
methylation decreased and was accompanied by upre-
gulation hoxd4 expression in both cells types (Fig. 4f).
These results thus indicate that the miR-10a-induced
inhibition of hoxd4 transcription is accompanied by de
novo DNA methylation and H3K27me3 formation in the
targeted promoter region.
Discussion
We demonstrate that an endogenous small noncding
RNA involved in transcriptional gene regulation in
human cells. This observation gives new insights into
the mechanisms by which an increase in the miR-10a
expression leads to a concomitant reduction in the hoxd4
expression. Bidirectional transcription leading to two
functionally different miRNAs originating from the same
genomic locus has been reported in flies [24-26]. Here,
we show that two miRNAs, miR-10a and miR-10b,
mapping to two different chromosomes, can target each
other's primary transcipts to repress the expression of
neighboring hox genes. Antisense RNA-mediated gene
silencing and de novo m e t h y l a t i o no fC p Gi s l a n d si nt h e
promoter have been demonstrated in humans [27].
However, the molecular mechanisms by which small
RNAs mediate DNA methylation of targeted promoter
regions in the human genome remains to be elucidated.
Some groups have observed siRNA-directed DNA
methylation at targeted promoters [9, 10, 28, 29]
whereas others have not found such an effect [19, 22]. A
recent report has showed that miR-10a could bind the
5'UTR of ribosomal protein mRNAs and enhance their
translation [30]. One possible explanation for this
observation might that non-coding RNAs are expressed
in the target region. It has been demonstrated that
promoter-associated noncoding RNAs can be recognized
by miRNAs and direct epigenetic silencing complexes to
the corresponding targeted promoters, thereby mediating
transcriptional inhibition [15]. In the case of the hoxd4
locus, the adjacent pri-miR-10b could serve as a promo-
ter-associated non-coding RNA, mediating induction of
transcriptional silencing when targeted by miR-10a.
Recently, Dicer has been reported to attenate abnormal
promoter DNA methylation in cancer cells [20]. Our
results define the first case in which an endogenous
miRNA targets and methylates a promoter region
through Dicer action. In plants, methylation is a crucial
step in microRNA biogenesis, and depends on HEN1, a
Figure 4
MiR-10a-induced transcriptional gene inhibition is
associated with DNA methylation of the hoxd4
promoter. (a) Effect of 5-aza-dC treatment on the p15,
gapdh and miR-10a expression levels in MCF7 cells.
Expression of p15 was upregulated when after treatment
with 5-aza-dC, but no changes were observed in the
expression level of miR-10a and gapdh gene. (b) Quantitative
RT-PCR analysis of hoxd4 expression after 5-aza-dC
treatment of MCF7 and MDA-MB-231 cells (c) 5-aza-dC
reverses miR-10a inhibition of hoxd4 gene expression in
MCF7 and MDA-MB-231 cells (□:M o c k ;■:m i R - 1 0 a : :A n t i -
miR-10a; : Mock + 5-aza-dC; □: miR-10a + 5-aza-dC;
: Anti-miR-10a + 5-aza-dC). (d) Western blot analysis of
H3K9me2 and H3K27me3 in the hoxd4 promotor. (e) ChIP
analysis of H3K27me3 and H3K9me2 levels in two regions
(box1 and box2) of the hoxd4 promotor (□:C o n t ;
■: miR-10a). (f) Bisulphate sequencing analysis of the
hoxd4 promotor methylation status in MCF7 and
MDA-MB-231 cells.
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most nucleotide of small non-coding RNAs in both
plants and mammals [31, 32]. miRNAs that regulate
Rbl2-dependent DNMT expression in mouse embryonic
stem cells have also been detected [29, 33]. Ago1 and
Ago4 has been shown to be involved in siRNA-directed
chromatin modification, including histone methylation
and non-CpG DNA methylation in plants and yeast [34,
35]. Ago1 is required for both siRNA-mediated transcrip-
tional gene silencing and the recruitment of histone
methyltransferase activity to H3K9me2 and H3K27me3
at a siRNA-targeted promoters in human cells [18], and
Ago3 has the ability to interact with methyltransferases
[36]. Here we show that Ago 1 and Ago3 participate in
miRNA-mediated de novo DNA methylation in human
cancer cells, further implicating both the miRNA
machinery and the chromatin remodelling complexes
in RNA directed transcriptional gene silencing.
Conclusion
Taken together, our data support the notion that an
RNA-operated system is involved in transcriptional
regulation of genes in human cells. Endogenous small
non-coding RNAs might control or fine-tune gene
expression at both the transcriptional and post-transcrip-
tional levels. An understanding of such a regulatory
system could prove valuable in targeted approaches to
specific control of gene expression and treatment of
human cancers.
Methods
Cell culture and transfection
Human breast cancer cell lines MCF-7, MDA-MB-231,
human mammary epithelial cell line MCF10A, human
cervical carcinoma cell line HeLa, human hepatocellular
liver carcinoma cell line HepG2, human lung adenocar-
cinoma cell line A549 were obtained from the American
Type Culture Collection (Rockville, MD). MCF10A cells
were cultured in DMEM-F12 (Life Technologies) supple-
mented with 5% horse serum, 0.5 μg/ml hydrocortisone
(Sigma), 10 μg/ml insulin (Sigma), 20 ng/ml epidermal
growth factor (Sigma), 100 μg/ml penicillin and 100 μg/
ml streptomycin. Other cells were grown in DMEM (Life
Technologies) supplemented with 100 μg/ml penicillin,
100 μg/ml streptomycin and 10% heat-inactivated FBS at
37°C in a humidified atmosphere containing 5% CO2.
Introduction of plasmids into tumor cells (3.5 × 10
6)
was performed with lipofectamine 2000 (Invitrogen)
according to the manufacturer's instructions.
R N Ai s o l a t i o na n dm i R N Ad e t e c t i o n
Total RNA from cultured cells was isolated using the
mirVana miRNA Isolation Kit (Ambion). Detection of
the mature form of miRNAs was performed using the
Hairpin-it miRNAs qPCR Quantitation Assay, according
to the manufacturer's instructions (GenePharma). The
U6 small nuclear RNA was used as an internal control.
Western blotting
Total protein (40 μg) was resolved with 10% SDS-
polyacrylamide gel eletrophoresis and bands of protein
transferred to a polyvinylidene difluoride (PVDF)
membrane (Amersham). The membrane was blocked
with 5% nonfat milk TBS buffer overnight at RT, and
incubated for 2 hours with primary antibodies. b-actin
was used as loading control. The antibodies used
included hoxd4 (Abcam), b-actin (SantaCruz Biotech-
nology). The membranes then were incubated for 1 h
with HRP-conjugated goat anti-mouse (Zymed Labora-
tories) or rabbit anti-goat (SantaCruz Biotechnology)
secondary antibody. Immunocomplexes were visualized
with an ECL kit (Pierce).
Methylation analysis and sodium bisulphite DNA
sequencing
Genomic DNA (1 μg) was treated with sodium bisul-
p h a t ea n d .u s e dt oP C R - a m p l i f yt h ehoxd4 promoter
regions (-300 bp – 122 bp). The amplifed product was
purified using a Qiagen PCR purification kit (Qiagen)
and sequenced using the sense primer with an ABI
automated fluorescent sequencer according to the
manufacturer's instructions.
Treatment of cells with 5'-aza-2'-deoxycytidine
(5-aza-dC)
MCF7 and MDA-MB231 breast cancer cells were treated
with 0.75 μM 5-aza-dC (Sigma), and collected 0, 3 and 5
days later. MCF7 and MDA-MB231 breast cancer cells
that had been transfected with 100 nM small RNA
duplexes were treated with 1 μM 5-aza-dC for 48 h after
transfection before subjected to qPCR analysis.
qRT-PCR
We extracted total RNA from the treated cells with Trizol
(Invitrogen) and treated it with DNase (Qiagen). We
carried out qRT-PCR analysis using QuantiTeck SYBR
Green PCR kit (Qiagen). PCR primers used in this paper
are listed in Table 1, Additional file 1. Real-time PCR was
performed with the LightCycler 2.0 (Roche).
Nuclear run-on assay
Nuclear run-on assays were performed in accordance
with the Current Protocols of Molecular Biology.
D i g o x i n u ml i n k e dd U T Pw a sa d d e dt oa nin vitro
transcription reaction and precipitated with digoxinum
antibody. Amplified b-actin served as a loading control.
B o u n dR N Aw a se l u t e df r o mt h eb e a d sb ya d d i n gT r i z o l
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(page number not for citation purposes)(Invitrogen) to the beads, followed by RNA extraction
and RT-real time PCR as described previously.
Chromatin immunoprecipitation
We cross-linked DNA and processed it in accordance
with the UpState Chromatin Immunoprecipitation
(ChIP) Assay Kit protocol (UpState 17-295). We used
2×1 0
6 cells for each immunoprecipitation reaction, and
used rabbit antibody to H3K27me3 (Upstate 07-449) for
specific immunoprecipitation of the histone residues.
The precipitates were analyzed by real-time PCR with
two sets of hoxd4 promoter specific primers spanning the
CpG island of interest (Table 1, Additional file 1).
Luciferase reporter assay
Cells of 50% confluence in 24-well plates were trans-
fected using Lipofectamine 2000 (Invitrogene). Firefly
luciferase reporter gene constructs (200 ng) and pRL-
SV40 Renilla luciferase construct (1 ng; for normal-
ization) were cotransfected per well. Cell extracts were
prepared 48 h after transfection, and the luciferase
activity was measured using the Dual-Luciferase Reporter
Assay System (Promega).
Statistical Analysis
All experiments were repeated 3 times. Data are
presented as mean ± s.e.m. Student's t test (two-tailed)
w a su s e dt oc o m p a r et w og r o u p s( P<0 . 0 5w a s
considered significant). Two asterisks indicated that the
p-value was less than 0.01, one asterisks indicated that
the p-value was less than 0.05.
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